Bruce C. Cozadd - 27 Feb 2025 Form 4 Insider Report for Jazz Pharmaceuticals plc (JAZZ)

Signature
By: /s/Paz Dizon, as attorney in fact For: Bruce C Cozadd
Issuer symbol
JAZZ
Transactions as of
27 Feb 2025
Net transactions value
-$937,625
Form type
4
Filing time
03 Mar 2025, 19:13:20 UTC
Previous filing
05 Feb 2025
Next filing
07 Mar 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction JAZZ Ordinary Shares Award $0 +30,814 +7% $0.000000 470,558 27 Feb 2025 Direct F1
transaction JAZZ Ordinary Shares Sale $937,625 -6,500 -1.4% $144.25 464,058 03 Mar 2025 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 These restricted stock units are granted pursuant to the Issuer's 2011 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. These units will vest in full on March 5, 2026.
F2 This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.